PHP293 - ORPHAN DRUGS IN GERMANY - LESSONS LEARNED FROM AMNOG, BEST AND WORST PRACTICES AND STRATEGIC IMPLICATIONS

Autor:	M. Schönermark, T. Kirchmann, A. Ewald
Rok vydání:	2018
Předmět:	Orphan drug 03 medical and health sciences 0302 clinical medicine 030503 health policy & services Health Policy Public Health Environmental and Occupational Health AMNOG 030212 general & internal medicine Business Public administration 0305 other medical science
Zdroj:	Value in Health. 21:S200
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5b29d64e360d34d8c6a5b89eb1a85450 https://doi.org/10.1016/j.jval.2018.09.1187 Zobrazit plný text záznamu Full Text from ScienceDirect